Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Cerimon Pharmaceuticals
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
In addition to others,
Men or women age 18-75
Diagnosis of ulcerative colitis confirmed through screening endoscopy.
Extent of disease must involve at least the left colon
Moderate to severe disease (Mayo Score 6-12). Systemic features of tachycardia, fever, and/or significant anemia should not be present.
Inadequate response despite treatment with prednisone 40 - 50 mg/day (or other oral steroid at equivalent dose) orally for a minimum of 14 days immediately preceding study entry
You may not be if
In addition to other protocol-defined conditions,
Pregnancy
Stool study that shows presence of ova and parasites, significant bacterial pathogens, or C. difficile toxin
Colitis that is indeterminate, suggestive of Crohn's disease, or isolated to the rectum, based on endoscopic and/or biopsy findings
Severely ill patients as evidenced by protocol-defined systemic criteria
Chest radiograph abnormalities consistent with an infectious process
History of colonic dysplasia
HIV infection
Known viral Hepatitis B or C infection
History of or exposure to tuberculosis within 6 months before study entry
